DÍVIDA Alterar Data
AstraZeneca USD 32.24B 1.68B 2026-06
Genmab DKK 5.35B 5.2B 2026-03
GlaxoSmithKline GBP 18.24B 818M 2026-06
GRIFOLS EUR 9.24B 723M 2026-09
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Qiagen NV USD 1.64B 2.94M 2026-06
UCB EUR 3.03B 12M 2024-12